AV fistula - search results

If you're not happy with the results, please do another search

The WavelinQ™ EndoAVF System takes an innovative approach in creating endovascular AV fistulas for...

This advertorial is ONLY available to watch in selected countries and geographies This advertorial, sponsored by BD, is intended for readers in the EMEA...

Wearable device for AV fistula remote monitoring shows promise—but faces commercial challenges

A new wearable device designed to remotely monitor arteriovenous (AV) fistulae function in dialysis access patients uncovered promising data leading one set of researchers...
PAVE

PAVE trial finds “no evidence of a benefit” from paclitaxel-coated balloons in preserving AV...

There is no evidence of a benefit from additional paclitaxel-coated balloon use compared to standard balloon angioplasty alone in the context of preserving arteriovenous...
MedAlliance SELUTION SLR

ISABELLA trial for the treatment of failing AV fistulas in haemodialysis patients completes enrolment

MedAlliance has announced completion of patient enrolment in the ISABELLA clinical trial with the Selution SLR 018 drug-eluting balloon (DEB) for the treatment of...
Surmodics

Six-month data from Surmodics Avess AV fistula DCB first-in-human study presented at VIVA 2020

Surmodics recently announced that six-month data from the AVESS first-in-human (FIH) study of the company’s Avess arteriovenous fistula (AVF) drug-coated balloon (DCB) was shared...
MedAlliance SELUTION SLR

First patient enrolled globally in SELUTION SLR study for AV fistulae

MedAlliance has announced enrolment of the first patient in the SAVE (Use of the Selution sirolimus-eluting balloon for dysfunctional AV access treatment indications) study...

Percutaneous AV fistulas “not actually sacrificing” options, but rather “expanding” them

Larry Scher (New York, USA) interviews John Aruny (Orangeburg, USA) and Stephen Hohmann (Dallas, USA) for VEITHtv at the VEITHsymposium (19–23 November, New York, USA) about the role of percutaneous...
Bard Covera stent

e-PTFE covered stent demonstrates “significantly better” target lesion primary patency compared to angioplasty out...

The results of AVeNEW, the first level one clinical study dedicated solely to the use of a covered stent designed to treat stenosis in...
covered

Covered stent provides greater patency than angioplasty alone in AV fistulae

The Covera vascular covered stent (BD) has a superior six-month primary patency rate than standard balloon angioplasty, with an equivalent safety at 30 days,...

Bard gets US FDA premarket approval for Lutonix 035 DCB in dysfunctional AV fistulae...

Bard’s Lutonix 035 drug-coated balloon PTA catheter (DCB) has been granted premarket approval (PMA) by the US Food and Drug Administration (FDA) for a...
Interventional News for specialists

AV fistulas remain dialysis gold standard at any age

Comparison by interventional radiologists shows no difference in patency of arteriovenous fistulas between young and old

IN.PACT™ AV Access trial shows improvement in patency “for the entire fistula”

 A trio of vascular experts including Raphaël Coscas (Paris, France), Alexandros Mallios (Paris, France) and Kate Steiner (Stevenage, UK) discuss the key findings of...

Lutonix AV results provide tailwind for drug-coated balloons in dysfunctional arteriovenous fistula treatment

Scott Trerotola presented the first release of eight-month data from the Lutonix AV IDE trial at the Leipzig Interventional Course (LINC; 24–27 January, Leipzig,...
ellipsys five-year data

Benefits of percutaneous fistula creation further bolstered by five-year Ellipsys data

The Ellipsys vascular access system (Avenu Medical/Medtronic) can be used to easily and safely create durable percutaneous arteriovenous fistulas (pAVFs) for haemodialysis—with new, long-term...

Utilising angioplasty to treat stenosis post EndoAVF

NOTE: This video is ONLY available to watch in selected countries and geographies This is advertorial sponsored by BD.  Reinterventions following WavelinQ™ EndoAVF System creation...

Screening with ultrasound and vessel mapping prerequisite to success with WavelinQ™ EndoAVF System

NOTE: This edtorial is ONLY available to read in selected countries and geographies This is advertorial sponsored by BD. Focusing on the importance of...

Patients’ wishes and multidisciplinary approach central to EndoAVF creation with WavelinQ

NOTE: This editorial is ONLY available to read in selected countries and geographies This advertorial is sponsored by BD. This advertorial is part of...

Minimally-invasive, outpatient WavelinQ offers an alternative to open surgery

NOTE: This video is ONLY available to watch in selected countries and geographies This advertorial is sponsored by BD. This advertorial is part of...

IN.PACT AV DCB sustained “superior” effectiveness in subgroups with high reintervention rates out to...

Several subgroups of patients treated with the IN.PACT AV drug-coated balloon (DCB; Medtronic) for arteriovenous fistulas (AVFs) demonstrated a “statistically significant” higher rate of...
fist assist fa-1 device

Fist Assist device achieves significant perforator vein dilation for improved endoAVF placement, p-FACT cohort...

Fist Assist Devices has announced that data associated with the p-FACT cohort, a subset of the recently completed, non-significant risk Fist Assist clinical trial...

Arteriovenous fistulas contribute to higher survival of haemodialysis patients with COVID-19

A new study, published online in The Journal of Vascular Access (JVA), suggests that arteriovenous fistulas (AVFs) contribute to higher survival of haemodialysis patients...

IN.PACT™ AV Access trial demonstrates “outstanding” patency rates & “significant” advantages through 24 months

 Andrew Holden (Auckland, New Zealand) presents the latest results from the IN.PACT™ AV Access trial (Medtronic), which indicate “outstanding” target-lesion primary patency rates of 52.2% through 24...
trerotola misra tan av access dcbs drug coated balloons

More mixed results for DCBs in AV access maintenance as evidence mounts

Additional randomised controlled data regarding the effectiveness of drug-coated balloons (DCBs) in maintaining arteriovenous (AV) access offers new evidence, but it is freighted with...

BD announces enrolment in postmarket studies of the WavelinQ endoAVF system

BD announced today that enrolment has begun and the first patients have been treated in the postmarket surveillance study, CONNECT-AV. CONNECT-AV is a prospective, single-arm,...
Medtronic IN.PACT AV

Two-year IN.PACT AV Access results presented at CX 2021

Medtronic recently announced the safety and effectiveness results through 24 months for the IN.PACT AV Access clinical study. The data, which were presented virtually...

CX to highlight impact of high-flow arteriovenous fistulas in Vascular Access session

Nicholas Inston (Queen Elizabeth Hospital Birmingham, Birmingham, UK) speaks to Vascular News ahead of this year’s Charing Cross Symposium (CX), which is being held online 19–22 April. In...

First patients enrolled in the Merit Wrapsody AV access efficacy pivotal study

Merit Medical Systems recently announced the enrolment of the first patients in its Wrapsody arteriovenous (AV) access efficacy pivotal (WAVE) study of the Wrapsody endovascular...
Medtronic IN.PACT AV

Medtronic launches IN.PACT AV DCB in Japan for patients undergoing haemodialysis

Medtronic has announced the launch of IN.PACT AV drug-coated balloon (DCB) in Japan. IN.PACT AV DCB is indicated for the treatment of obstructive lesions...

LINC 2021 first time data releases in arteriovenous access: Positive results for IN.PACT AV...

New data presented for the first time at LINC 2021 (The Leipzig Interventional Course; 25–29 January, online) are positive for the IN.PACT AV drug-coated...

24-month AVeNEW data show significantly better target lesion patency of Covera™ Vascular Covered Stent...

Bart Dolmatch (Portola Valley, USA) talks to Vascular News about some of the key data highlights from the 24-month AVeNEW trial, which compared the safety and efficacy...

Arterial diameter may help to predict AVF aneurysm progression, study suggests

A recent study concludes that arterial diameter may influence arteriovenous fistula (AVF) aneurysm progression and the interval to surgical revision. “Patients with larger arterial...
VasQ

VasQ device improves AVF creation in haemodialysis patients, JVA study reports

VasQ, a high haemocompatibility biosynthetic vascular device from Laminate Medical Technologies, could be protective against the haemodynamic modifications that occur during arteriovenous fistulae (AVF)...

Network meta-analysis finds DCB angioplasty “significantly superior” to plain balloon angioplasty in failing AVFs...

A recent network meta-analysis shows that, in failing arteriovenous fistulas (AVFs) with outflow stenosis, drug-coated balloon (DCB) angioplasty is “significantly superior” to plain balloon...

Risk of ischaemic steal syndrome and patency rate comparable for tapered and non-tapered AVGs

In their recent systematic review and meta-analysis, Venkata Sai Jasty (University of Arizona, Tuscon, USA) and colleagues found that the risk of ischaemic steal...

Study finds 3mm arteriotomy may be routinely utilised for brachiocephalic fistula creation

In a recently-published study, Jeremy Crane (Imperial College Healthcare NHS Trust, Hammersmith Hospital, London, UK) and colleagues conclude that a 3mm-long arteriotomy may be...
Medtronic

Medtronic to acquire Avenu Medical

Medtronic today announced the planned acquisition of Avenu Medical, a medical device company focused on the endovascular creation of arteriovenous (AV) fistulae for patients...
covered

24-month AVeNEW study results: Covered stent angioplasty “statistically superior” to angioplasty alone in ESRD...

Against the backdrop of increasing end-stage renal disease (ESRD) prevalence in the USA, Bart Dolmatch (Portola Valley, USA) presented the 24-month results of the...
Passeo-35

Biotronik’s Passeo-35 Xeo PTA balloon catheter is now available in Europe

Biotronik today announced European market release of the Passeo-35 Xeo percutaneous transluminal angioplasty (PTA) balloon catheter. A company press release states that, compared to...

Patient-specific computation model may improve AVF maturation rates

The results of a randomised controlled trial—the Shunt simulation study—show that a new patient-specific computation model accurately calculated postoperative access flow. As flow is...
Medtronic IN.PACT AV

Six-month IN.PACT AV Access results show superiority of DCB angioplasty

Just-published six-month results of the IN.PACT AV Access study show that drug-coated balloon (DCB) angioplasty is superior to standard angioplasty for the treatment of...

UK-first innovation could save lives of dialysis patients

Barts Health NHS Trust has performed a UK-first operation outside of trial setting that could reduce mortality and risks of infection in patients with...

Early AVeNEW trial results were “quite compelling”

 Throwback to the 2019 Society of Interventional Radiology annual scientific meeting when Interventional News interviewed Bart Dolmatch (Mountain View, USA) on the early results of the AVeNEW trial - the first Level One trial dedicated solely to assess the safety...

CX 2020 LIVE: Vascular Access session showcases new technologies, while debate on place of...

The CX 2020 LIVE Vascular Access Consensus session sparked global interest, with chair Nick Inston (Birmingham, UK) and moderator Domenico Valenti (London, UK) taking...
Interventional News for specialists

APERTO becomes the first drug-coated balloon to be approved in China for the treatment...

APERTO, Cardionovum’s paclitaxel-coated balloon for arterio-venous access, has received market approval for China, making it the first high pressure drug-coated balloon (DCB) available in...

LINC 2020: Positive new data for AV access interventions released

New arteriovenous (AV) access results were presented at the 2020 Leipzig Interventional Course (LINC; 28–31 January, Leipzig, Germany), including data on percutaneous AV fistula...
device designation for its sirolimus DEB

MedAlliance receives third FDA breakthrough device designation for its sirolimus DEB in the treatment...

MedAlliance, the first drug-eluting balloon (DEB) company in the world to receive US Food and Drug Administration (FDA) breakthrough device designation status for a...

BIBA Briefings: FDA approval of IN.PACT AV is a boon for management of dysfunctional...

Last month (November), the FDA approved Medtronic’s paclitaxel-coated balloon IN.PACT AV for the management of failing arteriovenous fistulae (AVF). Approval for the device was based...
endovascular

Endovascular arteriovenous fistulas “key part of any dialysis programme”

Endovascular arteriovenous fistulas (endoAVF) platforms add additional fistula options for patients and physicians, argues Dheeraj Rajan (University Health Network, University of Toronto, Toronto, Canada,...

Medtronic DCB receives US FDA approval to treat arteriovenous fistula lesions

Medtronic today announced US Food and Drug Administration (FDA) approval of the IN.PACT AV drug-coated balloon (DCB), a paclitaxel-coated balloon indicated for the treatment...

A panel of experts comments on IN.PACT AV ACCESS data

NOTE: This video is ONLY available to watch in selected countries and geographies   Jos van den Berg (Lugano, Switzerland) speaks to Andrew Holden (Auckland, New...
AV access

IN.PACT AV access trial meets primary safety and effectiveness endpoints

Medtronic has announced the first-ever results from the IN.PACT AV access clinical study comparing the investigational IN.PACT AV drug-coated balloon (DCB) to percutaneous transluminal...
breakthrough

MagicTouch AVF sirolimus-coated balloon granted FDA breakthrough device designation

Concept Medical has been granted breakthrough device designation from the US Food and Drug Administration (FDA) for MagicTouch AVF, its sirolimus drug-coated balloon (DCB)...
stem cell

Stem cell therapy shows promise in preventing venous stenosis and AVF maturation

 Sanjay Misra (Rochester, USA) talks to Interventional News about his research into whether stem cell therapy can help AVFs (arteriovenous fistulas) mature and also prevent venous...

Comparing and contrasting surgically-created AVFs with those made by endovascular means

 Nicholas Inston (Birmingham, UK) tells Vascular News at LINC 2019 about the exciting field of percutaneous arteriovenous fistula (AVF) creation, the main devices and...

BD receives FDA 510(k) clearance of WavelinQ 4F endoAVF system

BD has announced the 510(k) clearance from the US Food and Drug Administration (FDA) for the WavelinQ 4F endoAVF system earlier this month. The endoAVF...
paclitaxel

Paclitaxel DCB no better than placebo to treat stenosis in patients with arteriovenous fistulae

In a study evaluating the efficacy of a drug-coated balloon (DCB) in inhibiting restenosis and ensuring long-term patency in patients with arteriovenous fistulae (AVF),...

Lutonix Global AV Registry: DCB use prolongs time to reintervention in failing arteriovenous access

 Tobias Steinke (Dusseldorf, Germany) reported on the Lutonix Global arteriovenous (AV) Registry at CIRSE 2018 in Lisbon, Portugal. Lutonix Global AV Registry data add to...

BD acquires TVA Medical, makers of everlinQ endoAVF System

BD (Becton, Dickinson and Company) announced it has completed the acquisition of TVA Medical, a company that develops minimally invasive vascular access solutions...

FDA approves Ellipsys Vascular Access System for non-surgical dialysis fistula creation

Ellipsys Vascular Access System (Avenu Medical) has been granted De Novo marketing authorisation from the Food and Drug Administration (FDA). Ellipsys is a minimally-invasive...

everlinQ endoAVF receives FDA de novo marketing approval

everlinQ endoAVF System (TVA Medical) is now approved by the US Food and Drug Administration for de novo marketing. This innovative, minimally invasive technology...
interim

Latest data on Lutonix and IN.PACT drug-coated balloons in AV access revealed

There in an increasing physician interest in exploring the role of drug-coated balloons in arteriovenous (AV) access. At the Leipzig Interventional Course (LINC; 30...

Meta-analysis shows positive experience for patients who received an endovascular arteriovenous fistula for haemodialysis...

An international meta-analysis of clinical experience in patients who received an endovascular arteriovenous fistula (endoAVF) for haemodialysis access was presented at Leipzig Interventional Course...

Twelve-month NEAT trial data promising for everlinQ endoAVF haemodialysis access system

TVA Medical has announced the online publication of positive results from the Novel Endovascular Access Trial (NEAT) evaluating its everlinQ endoAVF system. The 12-month...

Novel arteriovenous fistula creation 
for dialysis access

Percutaneous arteriovenous fistulae creation may allow greater patient access to fistula formation as more physicians will be able to create these channels, thus potentially...

Novel, external pneumatic device may assist in fistula development

Extensive research has shown that intermittent compression and rubber tourniquets help to dilate superficial veins after fistula placement. The Fist Assist device is an...

TVA Medical presents positive everlinQ endoAVF system results at LINC 2017

TVA Medical has provided clinical updates involving its everlinQ endoAVF system at the 2017 Leipzig Interventional Course (LINC; 24–17 January, Leipzig, Germany). Scientific data were...

Percutaneously created arteriovenous fistulae need far fewer post-creation interventions than those made by traditional...

NEAT (Novel endovascular access trial) data presented at the Vascular Interventional Advances (VIVA) 2016 meeting (18–22 September, Las Vegas, USA) suggest that endovascular arteriovenous...

Medtronic IN.PACT Admiral DEB granted CE mark for treatment of AV access in patients...

The IN.PACT Admiral drug-eluting balloon (DEB) has been granted CE mark for arteriovenous (AV) access to help maintain haemodialysis access in patients with end-stage...

Interventional radiology of the occluded fistula

Scott O Trerotola, Philadelphia, USA told Interventional News that fistula declotting has become a mainstay of interventional radiology practices in the USA. He recently received a BSIR honorary membership at the annual meeting in Glasgow, UK.
Interventional News for specialists

TVA Medical’s catheter-based haemodialysis access system demonstrates success in clinical study

Preliminary data presented at the Cardiovascular and Interventional Radiological Society of Europe (CIRSE) annual scientific meeting (Barcelona, Spain) demonstrated that TVA Medical‰Ûªs vascular catheter-based FLEX System can create autogenous arteriovenous fistulas (AV fistulas) for haemodialysis patients with 94% procedural success.
Interventional News

Interventional News’ top 10 most popular stories of October 2021   

October’s top 10 features an interview with Maureen Kohi (Chapel Hill, USA), the chair and professor of Radiology (University of North Carolina), and the...

Global FACT trial reports significant superficial arm vein dilation with FA-1 device

Fist Assist Devices has just announced completion of the FACT trial, which evaluated the use of an intermittent pneumatic compression device, model FA-1, to...
amplifi vein dilation system

Artio Medical completes enrolment of first-in-human trial investigating Amplifi vein dilation system

Artio Medical announced today it has completed enrolment in its first-in-human study evaluating the Amplifi vein dilation system. In the study, five patients were treated...
top 10

Interventional News’ top 10 most popular stories for May 2021

Two of our top stories this month come from the International Symposium on Endovascular Therapy (ISET; 9–11 May, Miami, USA), which returned as an...

Study supports tunnelled haemodialysis catheter use for permanent dialysis access

In a recent study, Victor Demaerel (University Hospitals Leuven, Leuven, Belgium) and colleagues found that tunnelled haemodialysis catheter (THC) survival in 352 patients was...
MedAlliance SELUTION SLR

MedAlliance raises over US$50 million to roll out Selution SLR and begin enrolment of...

MedAlliance recently announced that it has raised over US$50 million in equity funding. The new investor is Trustar Capital (formerly known as CITIC Capital...
covera

Vascular access: Covera stent superior to plain balloon angioplasty in stenotic lesions

A covered stent provides significantly better target lesion primary patency than percutaneous transluminal angioplasty (PTA) of stenotic lesions in the venous outflow of upper...
covera

A thumbnail sketch of haemodialysis access: Past, present, and future in the USA

Bart Dolmatch gives an overview of the history of haemodialysis access in the USA, and balances the pros and cons of current access options....

Endovascular options gain ground in creation of haemodialysis lifelines

Until recently, creation, maintenance and restoration of vascular access function was entirely performed by open surgical methods. However, it is becoming apparent that endovascular...
stem cell

Promising first-time data indicate human stem cell trial is safe, prompting future efficacy study

A first-in-human, phase I clinical trial using stem cells to prevent venous stenosis formation in arteriovenous (AV) fistulas yields promising results. Sanjay Misra (Mayo...

Cagent Vascular raises US$11.87M funding

Cagent Vascular has announced the completion of US$11.87 million in Series B funding. The round was led by two strategic investors including one that...
Interventional News for specialists

First patient enrolled in IN.PACT arteriovenous access drug-coated balloon study

The US FDA has approved the investigational device exemption (IDE) study to evaluate the safety and efficacy of IN.PACT AV access drug-coated balloon as...

Interventional News Issue 64 – November 2016 US Edition

Highlights: 10-year EMMY results show majority undergoing embolization for symptomatic fibroids can avoid hysterectomy Percutaneously created AV fistulae need far fewer post-creation interventions than those made...

Interventional News Issue 64 – November 2016

Highlights: 10-year EMMY results show majority undergoing embolization for symptomatic fibroids can avoid hysterectomy Percutaneously created AV fistulae need far fewer post-creation interventions than those made...

Primary endpoint data from NEAT study announced at Leipzig Interventional Course 2016

Primary endpoint data from a prospective, multicentre clinical study evaluating the everlinQ endoAVF system have been announced by TVA Medical. The system is designed to...
wrapsody first study

“Very encouraging” 12-month data from WRAPSODY FIRST study presented at CIRSE 2021

Twelve-month results from a first-in-human study of the Wrapsody cell-impermeable endoprosthesis (Merit Medical Systems) for the treatment of access circuit stenosis in haemodialysis patients...

Treating the dysfunctional vascular access: The expert’s low-pressure, low-dose approach

NOTE: This advertorial is ONLY available to watch in selected countries and geographies This is advertorial sponsored by BD.  Panagiotis M Kitrou (Patras University Hospital, Patras,...
amplifi viva 2021

Results from first-in-human study of Amplifi vein dilation system presented at VIVA 2021

Preliminary clinical results from a first-in-human study assessing the Amplifi vein dilation system (Artio Medical) were presented at Vascular Interventional Advances (VIVA) 2021 (5–7 October...
MedAlliance SELUTION SLR

Eighteen-month PRESTIGE BTK data presented at VIVA 2021

Eighteen-month results from the PRESTIGE below-the-knee (BTK) study were presented as a late-breaking clinical trial at Vascular Interventional Advances (VIVA) 2021 (5–7 October, Las Vegas, USA). The...

Maureen Kohi

“I strongly believe that you cannot be what you cannot see. If you want more women or under-represented minorities (URMs) to enter the field...
Surmodics

Surmodics announces successful first patient uses of Sublime radial access 0.018 RX PTA dilatation...

Surmodics today announced the successful first clinical uses of the Sublime radial access 0.018 RX percutaneous transluminal angioplasty (PTA) dilatation catheter. Ankur Lodha, perfomed the...

First-in-human study of Wrapsody cell-impermeable endoprosthesis yields “very promising” results

Merit Medical Systems has announced positive results from a prospective, observational, first-in-human study to evaluate the safety and effectiveness of Wrapsody—a self-expanding, cell-impermeable endoprosthesis...

Bluegrass Vascular announces Medicare decision to assign New Technology Ambulatory Payment Classification for Surfacer...

Bluegrass Vascular Technologies (Bluegrass Vascular) announced today that the Centers for Medicare & Medicaid Services (CMS) has finalised a new Healthcare Common Procedure Coding...

Interventional News’ top 10 most popular stories for June 2021

June 2021 saw the publication of issue 82 of Interventional News, and both our cover stories were amongst those most widely-read on our site...

XO Score scoring sheath platform wins medical design award

Transit Scientific today announced that its XO Score scoring sheath platform has been named a winner in the 2021 Medical Design Excellence Awards (MDEA)....

XO Score scoring sheath platform earns CE mark approval

Transit Scientific recently announced it has received CE mark clearance in the European Union for the XO Score scoring sheath platform to facilitate dilation...
top 10

Interventional News’ top 10 most popular stories for April 2021

Three of our top 10 stories of April 2021 highlight new data and ideas presented at this year's Charing Cross (CX) Symposium, Digital Edition...

Vascular Therapies announces clinical results from phase 3 randomised multicentre clinical trial

Vascular Therapies recently announced results from its phase 3 clinical trial in which Sirogen showed encouraging arteriovenous fistula (AVF) outcomes in elderly end-stage renal...
td-cvc dialysis

Fluoroscopically-guided insertion of td-CVC found to be “low exposure”, despite large variability across procedure...

While there is large variability based on the site of insertion, patient characteristics and previous accesses, fluoroscopically-guided insertion of tunnelled central venous catheters (td-CVC)...
Surmodics

Surmodics announces first patient use of two Sublime radial access platform devices

Surmodics recently announced the successful first uses in patients for two devices within its Sublime radial access platform: the Sublime radial access guide sheath...

Shape Memory Medical receives PMDA approval for the Impede-FX embolisation plug

Shape Memory Medical recently announced that it has received approval from the Japanese Pharmaceuticals and Medical Devices Agency (PMDA) to market its Impede-FX embolisation...

Humacyte to present long-term follow-up data from Phase 2 vascular access trial at CX...

Humacyte has announced that the clinical results of five-year outcomes in patients receiving the human acellular vessels (HAV) for arteriovenous (AV) access in haemodialysis...

PatenSee initiates first-in-human trial with its contactless imaging surveillance system for haemodialysis patients

PatenSee has initiated a first-in-human clinical trial to assess its machine vision-based surveillance system, a press release from the company reveals. The trial, led...
interventional

Interventional News’ top 10 most popular stories for January 2021

Our top 10 stories of January 2021: musings on ethical decision-making during the COVID-19 pandemic, a reflection on the status and future of paediatric...

Transit Scientific announces close of its Series A financing round

Transit Scientific has announced the close of its Series A financing round. The round was led by a large multinational investor and joined by...
VasQ external support

VasQ external support awarded NUB Status 1 reimbursement renewal for 2021 for 321 hospitals

The German Institute for Hospital Remuneration (InEK) has renewed the new examination and treatment methods (NUB) Status 1 designation of VasQ external support (Laminate...
Avenu Ellipsys

Largest US nephrology group is first in Illinois to offer Ellipsys vascular access technology...

Nephrology Associates of Northern Illinois and Indiana (NANI), the largest nephrology group in the USA, is the first practice in Illinois to adopt the Ellipsys vascular access system (Avenu Medical, now...
laser

First-in-human study finds novel laser technique “safe and effective” for embedded filter removal

The excimer laser sheath technique is safe and effective for removing embedded inferior vena cava (IVC) filters refractory to high-force retrieval, the investigators of...

Adam Hatzidakis

The first person to perform a transjugular intrahepatic portosystemic shunt procedure (TIPS) in Greece, Adam Hatzidakis discusses his career-long love affair with the hepato-biliary-pancreatic...
Avenu Ellipsys

Case report shows Ellipsys system creates fused, permanent vascular access for dialysis

A new case report published in the Journal of Vascular Surgery (JVS) provides one of the first known opportunities to directly visualise the anastomosis...
patency

Older age and diabetes mellitus identified as risk factors for poor patency rates following...

Different risk factors affect patency between vascular access construction and the first percutaneous transluminal angioplasty, Mahoko Yoshida (Hiroshima University Hospital, Hiroshima, Japan) and colleagues...
deep vein arterialisation

Deep vein arterialisation should be considered in “no option” CLTI patients, two-year Limflow data...

Midterm results from a study of the largest population of patients with no-option chronic limb-threatening ischaemia (CLTI) treated with percutaneous deep vein arterialisation (pDVA)...
Avenu Ellipsys

Ellipsys system offers greater patient eligibility and reduced time to dialysis, study finds

Two devices for creating minimally invasive dialysis access—the Ellipsys vascular access system (Avenu Medical) and the WavelinQ 4F system (BD)—demonstrated high rates of technical...

Dialysis access needs to be a priority in the COVID-19 era

Panagiotis M Kitrou and Nicholas Inston discuss the impact of the COVID-19 pandemic on vascular access services. Despite the disruption caused, they are optimistic...
lymphadenectomy

Lipiodol offers an effective therapeutic option for melanoma patients suffering postoperative complications from radical...

Lymphatic fistulae and/or lymphoceles in the groin following radical lymphadenectomy are frequent, and therapeutic options are needed to avoid severe restrictions for oncologic patients...

Study finds Ellipsys system allows kidney patients to begin dialysis sooner with fewer interventions

The Ellipsys vascular access system reduces the time before patients with kidney failure can start lifesaving dialysis treatments, while requiring fewer secondary procedures, according...
Artio Medical

Artio Medical acquires Flow Forward Medical, expanding peripheral vascular portfolio

Artio Medical today announced it has acquired Flow Forward Medical, a medical device company developing methods for establishing and maintaining vascular access sites. This...

Balloon-expandable covered stent reveals promise as endovascular alternative to surgery in treatment of arterial...

This advertorial is sponsored by Bentley. Maria Antonella Ruffino, a vascular interventional radiologist at Azienda Ospedaliera Universitaria Città della Salute e della Scienza in Turin,...
MedAlliance SELUTION SLR

First sirolimus DEB patient enrolled in Japanese SELUTION SLR study

MedAlliance’s partner in Japan, MDK Medical, has enrolled the first patient in the clinical study of its novel sirolimus drug-eluting balloon (DEB), SELUTION SLR,...

New study shows advantages of Ellipsys system in creating reliable dialysis access

A new study shows significant benefits of the Ellipsys vascular access system (Avenu Medical) in easily and safely creating durable vascular access for end-stage...
CIRSE

The first virtual CIRSE: What you need to know

Ahead of the first ever virtual meeting of the Cardiovascular and Interventional Radiological Society of Europe (CIRSE), Thomas Kröncke, chairperson of the CIRSE 2020...

FDA clears Transit Scientific’s XO Score PTA scoring sheath platform

Transit Scientific has received US Food and Drug Administration (FDA) clearance for the XO Score percutaneous transluminal angioplasty (PTA) scoring sheath platform for use...
VasQ external support

VasQ external support awarded breakthrough device designation by the FDA

The US Food and Drug Administration (FDA) has designated Laminate Medical’s VasQ external support for the creation of arteriovenous fistulas (AVF) in haemodialysis patients...

Merit Medical’s Wrapsody System receives CE mark

Merit Medical has received CE mark approval for the Wrapsody endovascular stent graft system from the British Standards Institution. The Wrapsody system is a...
frostbite

Thrombolytic therapy performed by interventional radiologists could reduce amputation rates due to frostbite

An ahead-of-print article in the April issue of the American Journal of Roentgenology (AJR) reviewing various techniques and clinical management paradigms to treat severe...

FDA grants de novo clearance to Bluegrass Vascular for Surfacer system

Bluegrass Vascular Technologies (Bluegrass Vascular) announced today that the US Food and Drug Administration (FDA) has granted a de novo classification order for its...

Enrolment of the VasQ external support US pivotal study now complete

Laminate Medical Technologies has announced the completion of enrolment into the VasQ external support US pivotal study. The study was conducted at 17 sites...
kidney scale model

Medtronic begins pilot study as part of SPYRAL HTN clinical programme for renal denervation...

Medtronic has announced that it will begin enrolment in a pilot study evaluating the safety and efficacy of the Symplicity Spyral renal denervation (RDN)...

MedAlliance receives CE mark approval for SELUTION SLR sirolimus drug-eluting balloon for endovascular applications

MedAlliance has announced the award of its first CE mark approval: for SELUTION SLR, a novel sirolimus drug-eluting balloon (DEB), for the treatment of...
Flex

Flex vessel preparation system effectively limits potential complications in the femoral and popliteal arteries

The Flex vessel preparation system (VentureMed group) is safe and effective, and appears to limit the potential risks of dissection and perforation of chronic...
wrapsody

Merit Medical receives FDA breakthrough device designation for Wrapsody endovascular stent graft system

Merit Medical Systems has announced that it has been granted breakthrough device designation by the US Food and Drug Administration (FDA) for the Merit...
MagicTouch

Concept Medical granted CE certification for sirolimus-coated MagicTouch group of products

Concept Medical received CE certification for their MagicTouch group of products on 16 October 2019. The CE certified products/brands are as listed below: MagicTouch—PTA (sirolimus-coated...

High-grade evidence supports use of APERTO DCB in vascular access stenosis

Jos van den Berg (Lugano, Switzerland) tells Interventional News at CIRSE 2019 that the results of the APERTO AVF China trial provide strong evidence of the benefits of...
Luminor

Luminor DCB now reimbursed in France

Luminor 18 and Luminor 35 drug-coated balloons (DCB; iVascular) are now listed on the French LPPR list for de novo lesions of the femoropopliteal...
neuroendovascular

Transradial access is safe and effective for neuroendovascular procedures

In the largest cohort study to date, new research from Jefferson (Philadelphia University and Thomas Jefferson University, Philadelphia, USA) demonstrates that transradial surgery, done...
interim

Interim results of a multicentre analysis support paclitaxel-coated balloon angioplasty

The interim results of a multicentre, European retrospective analysis investigating the use of drug-coated balloons (DCBs) in symptomatic central venous stenosis (CVS) suggest that...

US FDA panel reviews paclitaxel device data: No recommendations issued

The US Food and Drug Administration (FDA) convened today and yesterday for a General Issues Panel Meeting on the late mortality safety signal associated...
Christof M Sommer, Thilo Hackert and Götz M Richter discuss the renaissance of Lipiodol-based lymphangiography

The renaissance of Lipiodol in lymphangiography and lymphatic interventions—Advertorial

This article is sponsored by Guerbet. Christof M Sommer, Thilo Hackert and Götz M Richter discuss the renaissance of Lipiodol-based lymphangiography following a decline in...
MDA

MHRA issues medical device alert for paclitaxel use in the UK

Do not use paclitaxel drug-coated balloons (DCBs) or drug-eluting stents (DESs) in the routine treatment of patients with intermittent claudication until further notice, a...

BD announces launch of UltraScore 014 Focused Force PTA Balloon

BD has announced the launch of their UltraScore 014 Focused Force percutaneous transluminal angioplasty (PTA) Balloon. This marks the first scoring balloon with sheath...
kidney

New clinical practice guidelines for management of chronic kidney disease

The National Kidney Foundation Kidney Disease Outcomes Quality Initiative (NKF KDOQI) provides evidence-based clinical practice guidelines for haemodialysis vascular access and related complications, and...
Stenting

Reviewing five years of deep venous stenting: What comes next?

For many venous specialists, dedicated venous stents represent the future—and the promise of an ideal venous stent on the horizon is a central topic...

Med Alliance raises US$37 million to launch sirolimus drug-coated balloon

Med Alliance SA, a company developing and commercialising the first sirolimus micro-reservoir drug-coated balloon (SELUTION DCB) to treat patients suffering from peripheral artery disease...

Addressing the data deficit for drug-coated balloon use in dialysis access

The first 24-month data from the LUTONIX AV investigational device exemption trial were presented at the Charing Cross Symposium in April. These interim data...

Robert Morgan

Robert Morgan, consultant vascular and interventional radiologist, St George’s Hospital, London, chairman of the CIRSE EBIR committee and a deputy editor on CVIR, told Interventional News...
bard and bd logo

EU Mergers Commission approves acquisition of Bard by BD

The European Commission, under the EU Merger Regulation, has approved the acquisition of Bard by BD, subject to conditions. Both US-based companies supply medical...

Bob Abraham

Canada’s recent recognition as a subspecialty at the national level has helped to raise awareness amongst other disciplines, healthcare policymakers and hospital administrators. “We...

Interventional News Issue 65 – Mar 2017 US Edition

Highlights: Pill that shrinks uterine fibroids gathers early data Lutonix AV results provide tailwind for drug-coated balloons in dysfunctional arteriovenous fistula treatment Michael Dake: TEVAR’s dirty secret Goetz Richter: MIRACLE I demonstrates high tumour...

Interventional News Issue 65 – Mar 2017

Highlights: Pill that shrinks uterine fibroids gathers early data Lutonix AV results provide tailwind for drug-coated balloons in dysfunctional arteriovenous fistula treatment Michael Dake: TEVAR’s dirty secret Goetz Richter: MIRACLE I demonstrates high tumour...

Bluegrass Vascular announces strategic relationship with Merit Medical

Bluegrass Vascular has announced that it is entering into a strategic relationship with Merit Medical. The agreement will streamline European distribution of the recently...

An update on the key results of the NEAT trial

The NEAT (Novel endovascular access trial) study demonstrates the possibility of using a catheter-based system to create an endovascular arteriovenous fistula (endoAVF) in patients...

From innovation to practice: The Ellipsys vascular access system

This is an exciting time for vascular access. Minimally invasive anastomosis devices have been developed and are being utilised in the creation of percutaneous...

Gireesh Mukund Warawdekar

“Interventional radiology has always been characterised by its innovative spirit. We are now seeing progress with new procedures being developed to create percutaneous arteriovenous fistulae....

Gregory John Slater

"War (as in turf war) is an emotional word because, in wars, people get hurt. I believe we truly care about the patients we...

Terumo acquires Sequent Medical

Terumo Corporation has announced that it has entered into an agreement to purchase Sequent Medical, known for its WEB aneurysm embolization device. The purchase price...
Interventional News for specialists

Nipro Medical launches Cronus HP high-pressure angioplasty balloon catheter in the USA

Nipro North America, a division of Nipro Medical Corporation, has launched the Cronus HP high-pressure, 0.035” over-the-wire percutaneous transluminal angioplasty balloon catheter. Cronus HP is...

Interventional radiology in trauma management

The role of interventional radiology in the management of severely traumatised patients began three to four decades ago with the embolization of the internal iliac arteries for massive pelvic bleeding. Over time, interventional radiology has progressively taken on a principal role in management of trauma patients, writes Jaime Tisnado.
Interventional News for specialists

NuCryo Vascular gets 510(k) clearance for next generation reusable Polarcath peripheral dilatation system

NuCryo Vascular has announced receiving 510(k) clearance on the next generation reusable Cryoplasty inflation device. The company has also announced that it will be selling the current and next generation model via a direct sales team.

Prospective multicentre study confirms safety and efficacy of percutaneous EVAR

The study confirms previous findings of single-centre studies that the procedure is associated with a high technical success rate when performed by experienced operators.

Splenic trauma: Know the limits of embolization

Management of blunt splenic trauma has substantially evolved during the past two decades. Hicham T Abada reviews the literature and outlines the limits of splenic embolization.

Aneurysm Coiling Efficiency (ACE) registry shows positive results for Ruby coil peripheral vasculature

The Aneurysm Coiling Efficiency registry offers an opportunity to study the demographics and long-term outcomes of a cohort of patients with embolization of the peripheral vasculature using Ruby coils (Penumbra).
Interventional News for specialists

Myths about interventional management of vascular malformations: general approach and diagnosis

Ahmad Alomari, Harvard Medical School, Boston Children‰Ûªs Hospital, Boston, USA, wrote to dispel common myths about the management and diagnosis of vascular malformations.

“Wait as long as you can to intervene”

At CIRSE Derrick Martin discussed different approaches, including interventional procedures, to managing pancreatic necrosis
Interventional News for specialists

Terumo introduces Azur Detachable 35 Peripheral Framing Coil

Azur (Terumo) is indicated for peripheral embolization procedures where a scaffolding structure is needed, such as: hypogastric artery embolization; peripheral arteriovenous malformations and fistulas; endoleaks; visceral aneurysms; and venous applications.
Interventional News for specialists

Boston Scientific launches Mustang PTA balloon catheter globally

On June 20, Boston Scientific announced the global launch of its Mustang PTA balloon catheter, a highly deliverable 0.035 inch percutaneous transluminal angioplasty (PTA) catheter designed for a wide range of peripheral angioplasty procedures.
Interventional News for specialists

AngioScore launches new longer AngioSculpt devices for treatment of peripheral artery disease

These new devices incorporate longer (40 mm) balloons and scoring elements in diameters 2.0, 2.5, 3.0 and 3.5mm. These new sizes are expected to be particularly useful in treating lesions typically encountered in the treatment of complex peripheral artery disease below the knee.
Interventional News for specialists

Opinion: Off-label use of devices and drugs by interventional radiologists

Tony Nicholson, consultant, Leeds Teaching Hospitals, NHS Trust, UK, spoke to Interventional News about the implications of off-label usage of devices and drugs by interventional radiologists.
Interventional News for specialists

Novel three-in-one angioplasty balloon achieves first commercial deployment successfully

The IQCath (Hotspur Technologies) enables, for the first time, performance of three complex vascular procedures with one single catheter, potentially reducing procedure time, expense and radiation exposure for patients and medical professionals.
Interventional News for specialists

Terumo launches Azur detachable 35 hydrocoil system

Terumo Interventional Systems has announced the full commercial availability in the United States of the Azur Peripheral HydroCoil 35 platinum coil embolization system.
Interventional News for specialists

Stent grafts top ‰ÛÏGold Standard‰Û balloon angioplasty for dialysis patients

New England Journal of Medicine publishes first study to show minimally invasive interventional radiology approach for end-stage kidney disease patients is ‰ÛÏsuperior‰Û in treating blocked access
Interventional News for specialists

Boston Scientific announces FDA clearance and CE mark for WallFlex fully covered oesophageal stent

Complete portfolio of the company‰Ûªs WallFlex stent family of self-expanding metal stents now available in US, Europe and other international markets
Interventional News for specialists

Opinion: Analysis on early treatment with PTFE-TIPS

Professor Ziv J Haskal MD, Vice Chair and Chief of Vascular and Interventional Radiology at the University of Maryland, Baltimore, US

Maureen Kohi

Philippe L Pereira

interventional

Parag Patel